XM无法为美国居民提供服务。

BOJ eases market migraine, Super Micro aches



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>MORNING BID AMERICAS-BOJ eases market migraine, Super Micro aches</title></head><body>

A look at the day ahead in U.S. and global markets from Mike Dolan

In an extraordinary round trip over the past week, world markets have rebounded sharply from days of turbulence - thanks in part to Bank of Japan almost apologising on Wednesday for its role in the ruckus - and traders now try to figure out what's next.

Japan's benchmark Nikkei stock index .N225 returned to Friday's close at one point earlier - completing a near 5,000 point, 12% roundabout in just three days and ending Wednesday's session about 1% higher.

As volatility gauges subsided back toward long-term averages, the BoJ's influential deputy governor Shinichi Uchida underscored the market recovery by saying the burst of market volatility that followed last week's interest rate rise and promise of more may in turn force the central bank to hold back.

"As we're seeing sharp volatility in domestic and overseas financial markets, it's necessary to maintain current levels of monetary easing for the time being," Uchida said in a speech to business leaders in the northern Japanese city of Hakodate.

At the heart of the problem over the past week was that the BoJ move seemed to puncture an estimated half trillion dollar yen-funded currency 'carry trade', catapulting the currency higher in the process. About two-thirds of those short yen positions may have already been unwound, according to estimates by JPMorgan.

The dollar/yen exchange rate JPY= has now rebounded 4% from Monday's 7-month low to reclaim a foothold above 147.

The VIX 'fear index' of U.S. stock market volatility has now returned to 23 - almost a third of Monday's peak and back closer to its historic average of 19.3.

Along with more sober assessments of the likelihood of U.S. recession any time soon, Wall Street's recovery looks set to continue later today - with futures for all major indexes ESc1, NQcv1, RTYc1 all up more than 1% ahead of the bell.

To the extent that global growth jitters were part of the market hiccup of the past week, Chinese trade numbers for July also helped settle things down a bit. Although Chinese export growth missed forecasts, imports were ahead of expectations.

Attention then switches back to the fundamentals of the earnings season and supercharged Federal Reserve rate cut bets.

If worries about pricey tech stocks and a reappraisal of the artificial intelligence theme was another reason for last week's upheaval, then Super Micro Computer's SMCI.O miss overnight may keep nerves jangling in that sector.

Super Micro's gross margins came in below estimates as high costs tied to the production of servers with the latest AI chips weighed on profits and sent its shares down 14%.

The read-across to other major chipmakers was limited so far - with AI torchbearer Nvidia NVDA.O still up 1.5% in pre-market trading on Wednesday.

What's more, overall second-quarter earnings remain impressive. Aggregate annual S&P500 profit growth is tracking 13.7% - more than two points higher than pre-season estimates, according to LSEG data.

And there are some big winners despite the recent tech wobble. Uber's UBER.N results beat Wall Street estimates on Tuesday on the back of steady demand for its ride-sharing and food-delivery services, lifting its shares 5%.

In interest rate markets, the broader stock market stabilisation has tempered the Fed view somewhat.

But a hefty 41 basis points of cuts next month is still priced by futures market and more than 100bps is still in the mix by the yearend.

Tuesday's $58 billion three-year Treasury auction went off without a hitch and some $42 billion of benchmark 10-year US10YT=RR goes under the hammer later today.

With a yield of 3.93%, Treasury is getting 10-year funding more than 20bp cheaper than if the auction was held this time last week.

As to recession worries more generally, there's little on Wednesday's diary to shift the dial on that - with tomorrow's jobless claims data likely to be a focus given the sudden bout of angst about labor market weakness.

For most investors, a 'soft landing' remains the best guess and stepped-up Fed rate cuts will only underscore that.

Franklin Templeton Institute's Stephen Dover points out that the average one year stock market return after the first Fed rate cut is almost 5% even when a recession occurs - but it's 16.6% when the cuts come without a recession materialising.

In Europe, pharma giant Novo Nordisk NOVOb.CO trimmed its full-year profit outlook after a sub-forecast sales update for its popular weight-loss drug Wegovy - stirring worries among investors about stiffening competition from Eli Lilly.

Elsewhere, politics dominated.

Democratic presidential nominee Kamala Harris and her newly selected vice presidential running mate, Minnesota Governor Tim Walz, campaigned for the first time together on Tuesday in Philadelphia.

The tailwind behind Harris' campaign has national opinion polls showing her slightly ahead of challenger Donald Trump, but betting markets have cut the odds of her taking the White House.

The PredictIt site now puts her chances of victory at some 57% - almost 10 points clear of Trump.


Key developments that should provide more direction to U.S. markets later on Wednesday:

* US June consumer credit

* Bank of Finland governor and European Central Bank policymaker Olli Rehn speaks

* US corporate earnings: Walt Disney, Warner Bros Discovery, Marathon, Occidental Petroleum, Mckesson, Atmos Energy, Emerson Electric, CVS Health, Monster Beverage, Ralph Lauren, Hilton Worldwide, Zimmer Biomet, Corpay, Global Payments, Equinix, CF Industries, Bio-Techne, Charles River Laboratories, NiSource etc

* US Treasury sells $42 billion of 10-year notes


Japan yen positions and carry trades https://tmsnrt.rs/4c7FJk4

The path to a Fed rate cut https://reut.rs/3SG1rot

Real Fed policy rate at 17year high https://tmsnrt.rs/3YxWEZW

China's exports growth slows, but imports up solidly https://reut.rs/3WAiHwz

Novo, Lilly have more than doubled in value https://tmsnrt.rs/4d9PeAx


By Mike Dolan, editing by Ros Russell;
mike.dolan@thomsonreuters.com

</body></html>

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明